Rifaximin: An Option for the Treatment of Irritable Bowel Syndrome
Objective: To study the response of irritable bowel syndrome patients presenting with diarrhea and abdominal pain to the treatment with Rifaximin. Study Design: Observational descriptive study. Place and Duration of Study: Study was carried out from 1st February 2019 to 1st December 2019 at Ga...
المؤلف الرئيسي: | Muhammad Abdul Quddus , Arslan Shahzad , Rukhsana Munawar , Khawaja Tahir Maqbool , Amna Mansoor , Naveed Gani , Sheikh Muhammad Taqqi Anwer |
---|---|
التنسيق: | مقال |
اللغة: | English |
منشور في: |
Riphah International University, Islamabad
2021-12-01
|
سلاسل: | Journal of Islamic International Medical College |
الموضوعات: | |
الوصول للمادة أونلاين: | https://journals.riphah.edu.pk/index.php/jiimc/article/view/1168 |
مواد مشابهة
-
Advances in Therapy for Irritable Bowel Syndrome with Diarrhea: Role of Rifaximin in Combination with Metronidazole
حسب: Arif A Faruqui
منشور في: (2024-01-01) -
Low dose rifaximin combined with N-acetylcysteine is superior to rifaximin alone in a rat model of IBS-D: a randomized trial
حسب: Gabriela Leite, وآخرون
منشور في: (2024-08-01) -
Rifaximin alleviates irinotecan-induced diarrhea in mice model
حسب: Chengyi Huang, وآخرون
منشور في: (2024-12-01) -
The role of rifaximin in irritable bowel syndrome derived from a network meta-analysis of randomized control trials
حسب: T. Rokkas, وآخرون
منشور في: (2020-07-01) -
Efficacy of Rifaximin Compared with Ciprofloxacin for the Treatment of Acute Infectious Diarrhea: A Randomized Controlled Multicenter Study
منشور في: (2010-09-01)